bims-mirnam Biomed News
on Mitochondrial RNA metabolism
Issue of 2026–11–01
six papers selected by
Hana Antonicka, McGill University



  1. BMC Bioinformatics. 2026 Oct 23. pii: 246. [Epub ahead of print]27(1):
      RNA modifications have emerged as key regulators of virtually all aspects of RNA biology, driving growing interest in computational approaches for their transcriptome-wide detection. For some RNA modifications, the search space can be reduced by exploiting characteristic sequence motifs, as exemplified by the canonical DRACH motif associated with m⁶A. However, comparable sequence preferences remain largely unknown for most other RNA modifications, making systematic motif discovery considerably more challenging. Here, we applied exponential population analysis to direct RNA sequencing data from HEK293T cells and peripheral human blood to identify candidate motif patterns for pseudouridine (Ψ), inosine (I), and 5-methylcytosine (m⁵C). Our results demonstrate that exponential population analysis provides a systematic framework for identifying candidate motif patterns from nanopore-derived RNA modification predictions, thereby prioritizing sequence contexts for future biological validation.
    Keywords:  Bioinformatics; Epitranscriptomics; Exponential population analysis; Nanopore direct RNA sequencing; RNA modifications; Sequence motif discovery
    DOI:  https://doi.org/10.1186/s12859-026-06724-5
  2. bioRxiv. 2026 Sep 06. pii: 2026.09.03.749114. [Epub ahead of print]
      The PNPase exoribonuclease interacts with the SUV3 helicase to form the human RNA Degradosome responsible for processive mitochondrial RNA turnover and quality control. Although structural data reveals the trimeric PNPase architecture along with the monomeric and dimeric states of SUV3, the molecular basis of their assembly for processive RNA degradation remains poorly understood. Here we present the molecular characterization of the human RNA Degradosome and define critical molecular features that regulate complex formation. We identify the protein regions required for RNA Degradosome formation and establish the minimum components necessary for the SUV3-PNPase interaction. Chemical crosslinking mass spectrometry analysis reveals distance restraints that position the SUV3 N-terminal domain alongside of the PNPase S1 domain, defining an important interface for complex formation. These findings provide mechanistic insight into how PNPase and SUV3 assemble to form the human RNA Degradosome.
    Keywords:  PNPase; RNA degradation; SUV3; helicase; ribonuclease
    DOI:  https://doi.org/10.64898/2026.09.03.749114
  3. bioRxiv. 2026 Oct 09. pii: 2026.10.07.757187. [Epub ahead of print]
      Ribonuclease Z enzymes remove 3' trailers from precursor tRNAs. In human cells, ELAC2/RNase Z L matures nuclear and mitochondrial pre-tRNAs, whereas the cytosolic short paralog ELAC1/RNase Z S repairs ANKZF1-cleaved tRNAs, but its broader substrate repertoire remains unclear. We investigated ELAC1 function using transcriptome profiling, small RNA sequencing, CLIP-seq, and biochemical reconstitution. ELAC1 was dispensable for canonical tRNA processing but associated with structured RNA polymerase III transcripts, prominently Y RNAs and vault RNAs (vtRNAs). Purified ELAC1 cleaved all four human vtRNAs near their 3' ends, with high-resolution mapping identifying a conserved cleavage position within the 3' extension. Efficient cleavage required structural features of the vtRNA terminal region. In contrast, ELAC2 showed little or no vtRNA cleavage under the conditions tested and displayed stricter substrate and cleavage-site selection on pre-tRNA. Loss and re-expression of ELAC1 altered structured ncRNA abundance and small-RNA end profiles. These findings identify vtRNAs as direct ELAC1 substrates and support functional specialization of human ELAC paralogs, with ELAC2 favoring precise pre-tRNA maturation and ELAC1 exhibiting broader RNA substrate specificity.
    DOI:  https://doi.org/10.64898/2026.10.07.757187
  4. Front Immunol. 2026 ;17 1952952
      RNA methylation serves as an essential post-transcriptional epigenetic modification for gene expression regulation. The methyltransferase-like (METTL) family is characterized by conserved methyltransferase domains. These members can recognize multiple RNA substrates including messenger RNA (mRNA), ribosomal RNA (rRNA), and mitochondrial RNA (mtRNA), and engage in a variety of RNA methylation processes. They exhibit markedly heterogeneous tumor-regulatory functions. The METTL3/14 complex regulates tumor proliferation, metastasis, metabolic reprogramming and immunotherapy resistance by catalyzing mRNA N6-methyladenosine (m6A) modification. METTL5 targets rRNA and drives translational reprogramming to participate in tumor progression and T cell immune resistance. METTL17 mediates multiple methylations of mtRNA to deregulate mitochondrial metabolism and drive malignant tumor phenotypes. METTL16 possesses both mRNA m6A catalytic and small nuclear RNA non-catalytic functions, and participates in tumor progression and immune escape. METTL4 catalyzes N6, 2'-O-dimethyladenosine methylation to modulate target gene translation and facilitate tumorigenesis. Beyond RNA methylation, METTL7A/B promotes resistance to tumor-targeted drugs via m6A-independent mechanisms of DNA binding and protein interactions. Notably, the same METTL protein yields distinct immunoregulatory effects in tumor cells, T cells, macrophages and natural killer cells, with obvious context-dependence. In this paper, we systematically summarize structural features and functions of METTL family proteins, together with mechanisms underlying their regulation of the tumor immune microenvironment. We also consolidate the research progress and transformation bottlenecks of multiple targeted candidate molecules. It provides a theoretical basis and new ideas for further investigations of METTL-based tumor immunotargeted therapy.
    Keywords:  METTL family; METTL inhibitor; antitumor; immune response; m6A modification; methyltransferase
    DOI:  https://doi.org/10.3389/fimmu.2026.1952952
  5. Environ Toxicol Pharmacol. 2026 Oct 28. pii: S1382-6689(26)00290-5. [Epub ahead of print] 105212
      Exposure to trichloroethylene (TCE) can cause occupational medicamentose-like dermatitis and severe immune-related kidney damage. Existing treatments focusing on TNF-α and complement pathways show limited effectiveness against TCE-induced kidney injury, with unclear molecular mechanisms. This study explores the involvement of mitochondrial double-stranded RNA (mt-dsRNA) in TCE-related kidney damage and its regulatory pathways. Patients with occupational medicamentose-like dermatitis due to TCE (OMDT) showed higher serum lipopolysaccharide (LPS) levels, especially in severe cases. Both in vivo and in vitro studies indicated that LPS reduced PNPT1 expression, leading to mt-dsRNA release, triggering the PKR/eIF2α/ATF4/CHOP pathway, causing endoplasmic reticulum (ER) stress and apoptosis. By boosting PNPT1 or inhibiting mitochondrial RNA polymerase with inhibitor of mitochondrial transcription 1(IMT1) decreased mt-dsRNA production and reduced cell damage. These findings suggest that TCE exposure increases systemic LPS, which suppresses PNPT1, causing pathological mt-dsRNA buildup. This activates PKR-dependent ER stress, leading to tubular injury.
    Keywords:  Endoplasmic reticulum stress; PNPT1; Trichloroethylene; mt-dsRNA
    DOI:  https://doi.org/10.1016/j.etap.2026.105212
  6. Case Rep Ophthalmol. 2026 Jan-Dec;17(1):17(1): 1031-1037
       Introduction: Hereditary optic neuropathies are mitochondrial disorders characterized by retinal ganglion cell degeneration and optic nerve dysfunction. Variants in MT-RNR1, a gene classically associated with aminoglycoside-induced and nonsyndromic sensorineural hearing loss, are increasingly recognized in hereditary optic neuropathy. We report the first case of hereditary optic neuropathy associated with the novel MT-RNR1 m.960delC variant, expanding the known genetic spectrum of this emerging mitochondrial optic neuropathy phenotype.
    Case Presentation: A 61-year-old woman presented with bilateral optic neuropathy characterized by optic disc pallor out of proportion to cupping, diffuse retinal nerve fiber layer and ganglion cell layer thinning, and bilateral visual field abnormalities. Best-corrected visual acuity was 20/30 in the right eye and 20/20 in the left eye, with intraocular pressures within the normal range. Gonioscopy demonstrated open angles bilaterally. Visual field testing demonstrated nonglaucomatous defects, and laboratory investigations were unremarkable. MRI of the orbits and brain with gadolinium was normal. Mitochondrial genetic testing identified the novel MT-RNR1 m.960delC variant at 87.2% heteroplasmy. The overall phenotype was consistent with hereditary optic neuropathy associated with mitochondrial dysfunction.
    Conclusion: This case expands the spectrum of MT-RNR1-associated hereditary optic neuropathy through identification of the novel m.960delC variant. The proximity of m.960delC to the previously reported m.956delC variant raises the possibility of a functionally important region within MT-RNR1. These findings further support MT-RNR1 as an emerging candidate gene in hereditary optic neuropathy, with important implications for genetic testing and disease recognition.
    Keywords:  Case report; Hereditary optic neuropathy; MT-RNR1; m960delC
    DOI:  https://doi.org/10.1159/cop/acaag016